Literature DB >> 18598198

Distinct outcomes of Trypanosoma cruzi infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression, and protein expression profile.

Angelina M Bilate1, Priscila C Teixeira, Susan P Ribeiro, Thales de Brito, Ana Maria Silva, Momtchilo Russo, Jorge Kalil, Edecio Cunha-Neto.   

Abstract

BACKGROUND: Trypanosoma cruzi-infected outbred hamsters reproduce the range of different outcomes of Chagas disease noted in humans. We tested whether myocarditis, its mediators, and myocardial protein expression are related to the severity of the acute phase of T. cruzi infection in the hamster model.
METHODS: Myocardium left ventricles (LVs) obtained from Syrian hamsters infected with T. cruzi were collected 21 days after infection. Myocarditis and the T. cruzi nest/antigen area were analyzed by histological and morphometric analysis. Cytokine and chemokine messenger RNA (mRNA) expression was analyzed using real-time reverse-transcriptase polymerase chain reaction. Differentially expressed proteins were identified by 2-dimensional electrophoresis, followed by mass spectrometry.
RESULTS: While in the acute phase of infection, 50% of animals displayed weight loss and signs of acute-phase infection (hereafter referred to as "acute-phase signs" [APS]) (e.g., lethargy, vomiting, and diarrhea). Both the T. cruzi nest/antigen area and the expression of interferon-gamma, tumor necrosis factor-alpha, interleukin-10, and CCL3 mRNA were significantly increased in the LVs of animals with APS, compared with the LVs of animals without APS. Animals with APS, those without APS, and uninfected animals demonstrated distinct myocardial expression of contractile, stress response, and metabolism proteins.
CONCLUSIONS: The distinct outcomes of acute T. cruzi infection in Syrian hamsters are related to cardiac parasitism, cytokine expression, and changes in the expression of structural/contractile and stress response proteins that may be associated with alterations in the cardiomyocyte cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598198     DOI: 10.1086/590347

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Cavia porcellus as a model for experimental infection by Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Noelia Angulo; Manuela Verastegui; Daniel E Velásquez; Charles R Sterling; Diana Martin; Caryn Bern
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

2.  Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.

Authors:  Eliziária C Santos; Rômulo D Novaes; Marli C Cupertino; Daniel S S Bastos; Raphael C Klein; Eduardo A M Silva; Juliana L R Fietto; André Talvani; Maria T Bahia; Leandro L Oliveira
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  The hamster (Mesocricetus auratus) as an experimental model of toxocariasis: histopathological, immunohistochemical, and immunoelectron microscopic findings.

Authors:  Ana Maria Gonçalves da Silva; Pedro Paulo Chieffi; Wellington Luiz Ferreira da Silva; Edite Hatsumi Yamashiro Kanashiro; Guita Rubinsky-Elefant; Edécio Cunha-Neto; Eliane Conti Mairena; Thales De Brito
Journal:  Parasitol Res       Date:  2014-12-19       Impact factor: 2.289

4.  Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil.

Authors:  Claudilson J C Bastos; Roque Aras; Gildo Mota; Francisco Reis; Juarez Pereira Dias; Robson Silva de Jesus; Miralba Silva Freire; Eline G de Araújo; Juliana Prazeres; Maria Fernanda Rios Grassi
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

Review 5.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

6.  MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes.

Authors:  Isabela Cunha Navarro; Frederico Moraes Ferreira; Helder I Nakaya; Monique Andrade Baron; Gláucia Vilar-Pereira; Isabela Resende Pereira; Ana Maria Gonçalves Silva; Juliana Monte Real; Thales De Brito; Christophe Chevillard; Joseli Lannes-Vieira; Jorge Kalil; Edecio Cunha-Neto; Ludmila Rodrigues Pinto Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18

7.  Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis.

Authors:  Ana M Espino; Francheska Rivera
Journal:  Vet Parasitol       Date:  2009-12-22       Impact factor: 2.738

Review 8.  Chagas' disease: an update on immune mechanisms and therapeutic strategies.

Authors:  Silvia Beatriz Boscardin; Ana Claudia Troccoli Torrecilhas; Romina Manarin; Silvia Revelli; Elena Gonzalez Rey; Renata Rosito Tonelli; Ariel Mariano Silber
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

9.  Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy.

Authors:  Amanda Farage Frade; Priscila Camilo Teixeira; Barbara Maria Ianni; Cristina Wide Pissetti; Bruno Saba; Lin Hui Tzu Wang; Andréia Kuramoto; Luciana Gabriel Nogueira; Paula Buck; Fabrício Dias; Helene Giniaux; Agnes Llored; Sthefanny Alves; Andre Schmidt; Eduardo Donadi; José Antonio Marin-Neto; Mario Hirata; Marcelo Sampaio; Abílio Fragata; Edimar Alcides Bocchi; Antonio Noedir Stolf; Alfredo Inacio Fiorelli; Ronaldo Honorato Barros Santos; Virmondes Rodrigues; Alexandre Costa Pereira; Jorge Kalil; Edecio Cunha-Neto; Christophe Chevillard
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

10.  CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy.

Authors:  Daniel Gibaldi; Glaucia Vilar-Pereira; Isabela Resende Pereira; Andrea Alice Silva; Leda Castaño Barrios; Isalira Peroba Ramos; Hílton Antônio Mata Dos Santos; Ricardo Gazzinelli; Joseli Lannes-Vieira
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.